SEC Form 4 · accession 0001638599-16-000558
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven R Hagen
Officer — SVP Manufacturing & Pharmaceut
Period of report
Jan 31, 2016
Accepted (ET)
Feb 1, 2016 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 31, 2016 | F | 529 | $15.97 | D | 33,171 | D | |
| Common Stock | Jan 31, 2016 | F | 529 | $15.97 | D | 32,642 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of shares withheld by Albany Molecular Research, Inc. in order to satisfy the minimum tax withholding obligation of the reporting person.